Allan Kalueff - Curriculum Vitae#

• 1989 - 1994 BS in Physiology, Moscow State University, Russia
  
• 2003 PhD in Physiology, RUDN State University, Moscow, Russia
  
• 2003 - 2005 Postdoctoral Fellow, Tampere University Medical School, Tampere, Finland
  
• 2005 PhD in Anatomy, Tampere University, Tampere, Finland
  
• 2005 - 2008 Postdoctoral Research Fellow in Neuroscience, NIMH/NIH, Bethesda, USA

• 2003 Cand Biol (PhD). Subject - Physiology: Neuroactive properties of penicillins and related beta-lactam compounds (RUDN University Medical School, Moscow, Russia)
  
• 2005 PhD. Subject - Anatomy: Neural abnormalities in mice with partially deleted vitamin D receptor gene (Tampere University Medical School, Tampere, Finland); with Honors [top 5%]]
  
• 2020 DrSci (Doctor of Science). Subject – Physiology. Biological bases of experimental modeling of CNS processes and human brain disorders using zebrafish (Danio rerio) (St. Peterburg State University, St. Petersburg, Russia)

• 2017 - present Professor of Pharmacology, School of Pharmacy, Southwest University, Chongqing, China
  
• 2015 - present Professor of Biological psychiatry, St. Petersburg State University, St. Petersburg, Russia
  
• 2021 - present Professor and Lab Chief, Sirius University, Sochi, Russia
  
• 2012 - present Research Director, ZENEREI, LLC., Slidell, LA, USA
  
• 2013 - 2017 Distinguished Chair Professor of Neuroscience, Guangdong Ocean University, China
  
• 2009 - 2012 Assistant Professor of Pharmacology, Tulane University Medical School, New Orleans
  
• 2008 - 2009 Assistant Professor of Physiology, Georgetown University Medical School, DC, USA
  
• 2005 - 2008 Post-doctoral Research Fellow, National Institute of Mental Health, Bethesda, USA
  
• 2003 - 2005 Post-doctoral Researcher, Medical School, Tampere University, Tampere, Finland
  
• 1996 - 2003 Director of Research, Centre for Physiology and Biochemical Research, Kiev, Ukraine
  
• 1996 Visiting Researcher, University of Birmingham Medical School, Birmingham, UK
  
• 1995 Academic Research Visitor, Bristol University Medical School, Bristol, UK

• Current H-index 67 (Google Scholar), 56 (Scopus/WoS) March 2021
  
• Total citations: >16200; 40 papers cited > 100 times (highly cited publications)
  

• 1993 - 1994 Rector’s Fellowship Award, Moscow State University
  
• 1995 President of Russia Scientific Prize for outstanding young scientists
  
• 1995, 1996 Graduate Fellowship, International Science Foundation
  
• 1997, 2001 Young Investigator Awards, International Union of Physiological Societies
  
• 2000, 2005 Young Investigator Awards, World Federation of Societies of Biological Psychiatry
  
• 2005 Medal for Neurosteroid Research, Finland
  
• 2006 Mudry Medal for excellence in education, National Academy, Kiev, Ukraine
  
• 2005 - 2008 IRTA Postdoctoral Fellowship, NIMH, NIH
  
• 2007 - 2009 NARSAD Young Investigator Award
  
• 2009 - 2012 Newcomb Fellow, Newcomb College Institute, Tulane University

• 2005 - 2019 Letters in Drug Discovery and Design
  
• 2008 - present Progress in Neuro-Psychopharmacology and Biological Psychiatry
  
• 2012 - 2017 PLoS One (Biology Academic Editor)
  
• 2013 - present Associate Editor, Frontiers in Neurosciences (FBN)
  
• 2015 - present Neuroscience and Biobehavioural Reviews
  
• 2017 - 2019 Trends in Pharmacological Sciences
  
• 2019 - present Pharmacology and Drug Toxicology
  
• 2018-2020 Neurology, Psychiatry and Brain Research

• 1996 European Science Foundation Neuroscience Program Award ($20,000, PI)
  
• 2003 - 2005 CIMO Finland Young Investigator Award ($40,000, PI)
  
• 2003 - 2005 Tampere Finland Medical Research Grants ($15,000, PI)
  
• 2007 - 2010 NARSAD Young Investigator Award ($60,000, PI)
  
• 2009 - 2010 Tulane-LSU Pilot CRECP Grant ($50,000, PI)
  
• 2010 LA Board of Regents P-Fund grant ($10,000, PI)
  
• 2011 - 2012 NIH/NIDA R03 SOAR Grant and supplement ($85,000, PI)
  
• 2011 Tulane University Pilot Grant ($25,000, PI)
  
• 2012 LA BoR Opt-In II Grant ($ 20,000, PI)
  
• 2016 - 2018 Russian Foundation for Basic Research grant ($25,000, PI)
  
• 2017 - 2020 Platform Construction Fund, SWU ($360,000, PI)
  
• 2018- 2019 Russian Science Foundation ($300,000, PI)
  
• 2020 - 2023 Russian Science Foundation ($360,000, Lead Res)
  
• 2020 - 2021 St. Petersburg State University State Budget Fund ($100,000, PI)
  
• 2020 - 2022 Granov Medical Center State Budget Fund ($210,000, PI)
  
• 2020 - 2023 Almazov National Medical Center State Budget Fund ($210,000, PI)
  
• 2021 - 2023 Intramural Research Funding, Sirius University ($300,000, PI)

• Rudolf Magnus Lecture, Rudolph Magnus Institute of Neuroscience, Utrecht, Netherlands, May 2008
  
• Inaugural speaker, 1st Neuroscience Symposium, Arkansas Tech University, Russellville, AR, October 2009
  
• Invited speaker, 3rd Addiction Neurobiology Conference, San Antonio, TX, March 2010
  
• Inaugural Speaker, Stress Physiology Center Seminars, University of Minnesota, Minneapolis, April 2011
  
• Institute Lecture, Max Planck Institute for Psychiatry, Munich, May 2012
  
• Symposium Chair/Speaker, 4th Behavior, Biology and Chemistry of Addiction, San Antonio, March 2012
  
• Conference Chair/Speaker, 25th International “Stress and Behavior” Conference, St. Petersburg, May 2018
  
• Keynote Speaker, 1st Inaugural Congress of South African Biomedical Societies, Johannesburg, October 2019

• Team-taught courses in Aging AGST702 and AGST706; Principles in Pharmacology GPHR 7230, Pharmacology research methods GPHR 7500, Tulane University (2009 - 2012)
  
• Director, Medical Pharmacology (T2), Research Methods in Neuroscience NSCI 6150, Advanced Studies in Psychology PSYC 661-662, Tulane University (2009 - 2012)
  
• Director, Physiology Seminars, Georgetown University (2008 - 2009)
  
• General Physiology and Neuroscience course, Guangdong Ocean University (2014 - 2016)

• Peer-reviewed articles in Neuroscience and Pharmacology: 250 (WoS/Scopus)
  
• Edited Special Issues of scholarly journals 6